首页> 外文期刊>Indian Journal of Ophthalmology >Intravitreal sustained-release dexamethasone implant for the treatment of persistent cystoid macular edema in ocular syphilis
【24h】

Intravitreal sustained-release dexamethasone implant for the treatment of persistent cystoid macular edema in ocular syphilis

机译:玻璃体缓释地塞米松植入物治疗眼梅毒持续性囊样黄斑水肿

获取原文
           

摘要

With a resurgence of syphilis with human immunodeficiency virus (HIV) infection in last few years, various ocular manifestations of syphilis have been described in literature. This case report described an HIV-positive patient on anti-retroviral therapy who was diagnosed and treated for posterior uveitis secondary to ocular syphilis in the recent past presented to our clinic with cystoid macular edema (CME). CME, which did not respond to periocular corticosteroid, resolved with intravitreal sustained release dexamethasone implant. There was a recurrence CME 9 months later and repeat injection of intravitreal implant showed complete resolution. A long-term follow-up did not reveal reactivation of the infection with intravitreal corticosteroid. Intravitreal sustained release dexamethasone implant can be an effective treatment for refractory CME in patients with regressed syphilitic uveitis.
机译:近年来,随着人免疫缺陷病毒(HIV)感染引起的梅毒死灰复燃,文献中描述了梅毒的各种眼部表现。该病例报告描述了一名接受抗逆转录病毒疗法治疗的HIV阳性患者,该患者最近被诊断为眼梅毒继发性葡萄膜炎并向我们的诊所呈囊性黄斑水肿(CME)治疗。 CME对眼周皮质类固醇无反应,用玻璃体内缓释地塞米松植入物解决。 9个月后发生了CME复发,玻璃体内植入物的重复注射显示出完全的分辨率。长期随访未发现玻璃体内皮质类固醇感染会重新激活。玻璃体缓释地塞米松植入物可有效治疗梅毒性葡萄膜炎患者难治性CME。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号